| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Seth Lederman is Chief Executive Officer at TNXP. From October 2016 to August 2026, the filings on record show 26 open-market purchases and 0 sales. Seth Lederman's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $57K at current prices.
Historically, Seth Lederman's trades have earned a below-average insider score of 28/100 across 8 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -77.3%.
Net of sales, the TNXP filings show accumulation of 496,533 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2017 | TNXP Tonix Pharmaceuticals Holding Corp. | Chief Executive Officer | Buy | 20,000 | $3.00 | $60,017.50 | +66.7% | |
| Jun 30, 2017 | TNXP Tonix Pharmaceuticals Holding Corp. | Chief Executive Officer | Buy | 5,000 | $4.33 | $21,640.00 | +20.0% | |
| Jun 26, 2017 | TNXP Tonix Pharmaceuticals Holding Corp. | Chief Executive Officer | Buy | 5,000 | $4.40 | $21,999.50 | +25.0% | |
| Jun 20, 2017 | TNXP Tonix Pharmaceuticals Holding Corp. | Chief Executive Officer | Buy | 20,000 | $4.22 | $84,400.00 | New | |
| Nov 21, 2016 | TNXP Tonix Pharmaceuticals Holding Corp. | Chief Executive Officer | Buy | 98,000 | $0.43 | $41,924.40 | +280.0% | |
| Oct 31, 2016 | TNXP Tonix Pharmaceuticals Holding Corp. | Chief Executive Officer | Buy | 10,000 | $0.00 | - | +12.4% |